| Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells MB Fuertes, AK Kacha, J Kline, SR Woo, DM Kranz, KM Murphy, ... Journal of Experimental Medicine 208 (10), 2005-2016, 2011 | 1234 | 2011 |
| CD47 blockade by Hu5F9-G4 and rituximab in non-Hodgkin’s lymphoma R Advani, I Flinn, L Popplewell, A Forero, NL Bartlett, N Ghosh, J Kline, ... New England Journal of Medicine 379 (18), 1711-1721, 2018 | 939 | 2018 |
| CD47 blockade triggers T cell–mediated destruction of immunogenic tumors X Liu, Y Pu, K Cron, L Deng, J Kline, WA Frazier, H Xu, H Peng, YX Fu, ... Nature medicine 21 (10), 1209-1215, 2015 | 708 | 2015 |
| Immune resistance orchestrated by the tumor microenvironment TF Gajewski, Y Meng, C Blank, I Brown, A Kacha, J Kline, H Harlin Immunological reviews 213 (1), 131-145, 2006 | 526 | 2006 |
| PD-1/PD-L1 interactions inhibit antitumor immune responses in a murine acute myeloid leukemia model L Zhang, TF Gajewski, J Kline Blood, The Journal of the American Society of Hematology 114 (8), 1545-1552, 2009 | 464 | 2009 |
| Costimulatory and coinhibitory receptors in anti‐tumor immunity G Driessens, J Kline, TF Gajewski Immunological reviews 229 (1), 126-144, 2009 | 368 | 2009 |
| Axicabtagene ciloleucel in the non-trial setting: outcomes and correlates of response, resistance, and toxicity CA Jacobson, BD Hunter, R Redd, SJ Rodig, PH Chen, K Wright, ... Journal of Clinical Oncology 38 (27), 3095, 2020 | 260 | 2020 |
| Geriatric assessment to predict survival in older allogeneic hematopoietic cell transplantation recipients LS Muffly, M Kocherginsky, W Stock, Q Chu, MR Bishop, LA Godley, ... Haematologica 99 (8), 1373, 2014 | 238 | 2014 |
| Reduced-intensity conditioning with combined haploidentical and cord blood transplantation results in rapid engraftment, low GVHD, and durable remissions H Liu, ES Rich, L Godley, O Odenike, L Joseph, S Marino, J Kline, ... Blood, The Journal of the American Society of Hematology 118 (24), 6438-6445, 2011 | 200 | 2011 |
| Molecular profiling to identify relevant immune resistance mechanisms in the tumor microenvironment TF Gajewski, M Fuertes, R Spaapen, Y Zheng, J Kline Current opinion in immunology 23 (2), 286-292, 2011 | 170 | 2011 |
| Nivolumab combined with brentuximab vedotin for relapsed/refractory primary mediastinal large B-cell lymphoma: efficacy and safety from the phase II CheckMate 436 study PL Zinzani, A Santoro, G Gritti, P Brice, PM Barr, J Kuruvilla, ... Journal of Clinical Oncology 37 (33), 3081, 2019 | 169 | 2019 |
| STING pathway activation stimulates potent immunity against acute myeloid leukemia E Curran, X Chen, L Corrales, DE Kline, TW Dubensky, P Duttagupta, ... Cell reports 15 (11), 2357-2366, 2016 | 166 | 2016 |
| The immune landscape and response to immune checkpoint blockade therapy in lymphoma J Kline, J Godfrey, SM Ansell Blood, The Journal of the American Society of Hematology 135 (8), 523-533, 2020 | 152 | 2020 |
| Immune evasion in acute myeloid leukemia: current concepts and future directions RM Teague, J Kline Journal for immunotherapy of cancer 1, 1-11, 2013 | 134 | 2013 |
| PD‐1 regulates extrathymic regulatory T‐cell differentiation X Chen, D Fosco, DE Kline, L Meng, S Nishi, PA Savage, J Kline European journal of immunology 44 (9), 2603-2616, 2014 | 116 | 2014 |
| Dendritic cells coordinate the development and homeostasis of organ-specific regulatory T cells DS Leventhal, DC Gilmore, JM Berger, S Nishi, V Lee, S Malchow, ... Immunity 44 (4), 847-859, 2016 | 114 | 2016 |
| Homeostatic proliferation as an isolated variable reverses CD8+ T cell anergy and promotes tumor rejection IE Brown, C Blank, J Kline, AK Kacha, TF Gajewski The Journal of Immunology 177 (7), 4521-4529, 2006 | 111 | 2006 |
| Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma J Kline, IE Brown, YY Zha, C Blank, J Strickler, H Wouters, L Zhang, ... Clinical Cancer Research 14 (10), 3156-3167, 2008 | 110 | 2008 |
| Leukemia cell–targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity DMS Hossain, C Dos Santos, Q Zhang, A Kozlowska, H Liu, C Gao, ... Blood, The Journal of the American Society of Hematology 123 (1), 15-25, 2014 | 108 | 2014 |
| PD-L1 gene alterations identify a subset of diffuse large B-cell lymphoma harboring a T-cell–inflamed phenotype J Godfrey, S Tumuluru, R Bao, M Leukam, G Venkataraman, J Phillip, ... Blood, The Journal of the American Society of Hematology 133 (21), 2279-2290, 2019 | 106 | 2019 |
